Live
- Summer Essentials: Beat the Heat in Style
- Spectacular getaways to visit this Summer
- SP Gaikwad Vaibhav Raghunath returned the lost cell phone to the 52 victims
- Polling booth vandalized in Chamarajanagar
- We will implement UCC in entire country, it is 'Modi ki Guarantee': Amit Shah
- Outer Manipur: Over 54 pc turnout recorded till 1 p.m. in 8 districts
- Ahead of selection day, looking at India's likely squad for the T20 World Cup
- CM Jagan Focuses on Manifesto Preparation, convenes meeting with key leaders
- Investment opportunities in Indian hospitality
- Nomination of BJP’s Birbhum candidate cancelled, Debtanu Bhattacharya to contest
India’s first ‘Blue Tongue’ vaccine launched
Indian Immunologicals Limited (IIL), a wholly owned subsidiary of the National Dairy Development Board (NDDB), introduced the first ‘Blue Tongue’ disease vaccine which would be developed in India. IIL is a leading bio pharmaceutical company and the largest veterinary vaccine manufacturer and exporter.
Indian Immunologicals Limited (IIL), a wholly owned subsidiary of the National Dairy Development Board (NDDB), introduced the first ‘Blue Tongue’ disease vaccine which would be developed in India. IIL is a leading bio pharmaceutical company and the largest veterinary vaccine manufacturer and exporter.
Blue tongue is a viral disease which mainly affects sheep. Goats, camels and cattle are also affected by this disease. India is endemic to the Blue Tongue disease since it has a large population of about 70 million sheep.
There are 24 viral strains prevalent in the world. However, in India, only five strains are predominant. Blue tongue disease results in more than 30 per cent mortality and causes high level of morbidity. Until now, no vaccine has been developed to protect against the strains prevalent in India. Treatment of Blue tongue disease is also expensive.
IIL developed the inactivated Blue Tongue disease vaccine in collaboration with TANUVAS (Tamilnadu University of Veterinary and Animal sciences) & ICAR and conducted extensive multi-centric trials in reputed institutes to prove its safety and efficacy. RAKSHA-BLU is the brand name of the IIL’s Blue Tongue vaccine. RAKSHA-BLU is a pentavalent vaccine, incorporating the five strains of Blue Tongue virus prevalent in India. RAKSHA-BLU would be available to farmers at Rs 5 per dose.
